Cytori Cell Research Institute, Inc. (TYO:3750)
Japan
· Delayed Price · Currency is JPY 692.00
-6.00 (-0.86%)
May 23, 2025, 3:30 PM JST
TYO:3750 Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Cash & Equivalents | 255 | 1,038 | 1,123 | 851 | 1,069 | Upgrade
|
| Cash & Short-Term Investments | 255 | 1,038 | 1,123 | 851 | 1,069 | Upgrade
|
| Cash Growth | -75.43% | -7.57% | 31.96% | -20.39% | 7.01% | Upgrade
|
| Accounts Receivable | 2 | 58 | 113 | 117 | 81 | Upgrade
|
| Receivables | 2 | 58 | 113 | 117 | 81 | Upgrade
|
| Inventory | 44 | 103 | 116 | 1,646 | 5,028 | Upgrade
|
| Other Current Assets | 216 | 228 | 36 | 415 | 92 | Upgrade
|
| Total Current Assets | 517 | 1,427 | 1,388 | 3,029 | 6,270 | Upgrade
|
| Property, Plant & Equipment | 2,960 | 4,217 | 11,727 | 12,041 | 7,466 | Upgrade
|
| Long-Term Investments | 58 | 149 | 130 | 194 | 386 | Upgrade
|
| Goodwill | - | - | 647 | 693 | 739 | Upgrade
|
| Other Intangible Assets | 2 | 21 | 41 | 49 | 61 | Upgrade
|
| Long-Term Deferred Tax Assets | - | - | 157 | - | - | Upgrade
|
| Other Long-Term Assets | - | 2 | 1 | - | 2 | Upgrade
|
| Total Assets | 3,537 | 5,816 | 14,091 | 16,006 | 14,924 | Upgrade
|
| Short-Term Debt | 300 | 70 | 500 | 164 | - | Upgrade
|
| Current Portion of Long-Term Debt | 54 | 54 | 401 | 553 | 520 | Upgrade
|
| Other Current Liabilities | 137 | 412 | 272 | 278 | 215 | Upgrade
|
| Total Current Liabilities | 491 | 536 | 1,173 | 995 | 735 | Upgrade
|
| Long-Term Debt | 2,293 | 2,347 | 7,605 | 8,550 | 8,013 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 110 | 125 | 1,436 | 1,517 | 1,400 | Upgrade
|
| Other Long-Term Liabilities | 13 | 14 | 1,221 | 1,229 | 1,229 | Upgrade
|
| Total Liabilities | 2,907 | 3,022 | 11,435 | 12,291 | 11,377 | Upgrade
|
| Common Stock | 100 | 100 | 100 | 100 | 100 | Upgrade
|
| Additional Paid-In Capital | 2,939 | 2,939 | 2,939 | 2,939 | 2,678 | Upgrade
|
| Retained Earnings | -2,618 | -458 | -596 | 462 | 543 | Upgrade
|
| Treasury Stock | -1 | -1 | -1 | - | - | Upgrade
|
| Comprehensive Income & Other | 210 | 210 | 210 | 211 | 223 | Upgrade
|
| Total Common Equity | 630 | 2,790 | 2,652 | 3,712 | 3,544 | Upgrade
|
| Minority Interest | - | 4 | 4 | 3 | 3 | Upgrade
|
| Shareholders' Equity | 630 | 2,794 | 2,656 | 3,715 | 3,547 | Upgrade
|
| Total Liabilities & Equity | 3,537 | 5,816 | 14,091 | 16,006 | 14,924 | Upgrade
|
| Total Debt | 2,647 | 2,471 | 8,506 | 9,267 | 8,533 | Upgrade
|
| Net Cash (Debt) | -2,392 | -1,433 | -7,383 | -8,416 | -7,464 | Upgrade
|
| Net Cash Per Share | -267.91 | -159.95 | -826.90 | -953.13 | -911.98 | Upgrade
|
| Filing Date Shares Outstanding | 8.93 | 8.93 | 8.93 | 8.93 | 8.74 | Upgrade
|
| Total Common Shares Outstanding | 8.93 | 8.93 | 8.93 | 8.93 | 8.71 | Upgrade
|
| Working Capital | 26 | 891 | 215 | 2,034 | 5,535 | Upgrade
|
| Book Value Per Share | 70.56 | 312.49 | 297.03 | 415.74 | 406.84 | Upgrade
|
| Tangible Book Value | 628 | 2,769 | 1,964 | 2,970 | 2,744 | Upgrade
|
| Tangible Book Value Per Share | 70.34 | 310.14 | 219.97 | 332.63 | 315.01 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.